Literature DB >> 4053238

Spectrofluorometric determination of FUT-175 (nafamstat mesilate) in blood based on trypsin-inhibitory activity.

T Aoyama, H Sasaki, M Shibuya, Y Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4053238     DOI： 10.1248/cpb.33.2142

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  3 in total

1.  Abstracts of selected papers presented at the 74th general meeting of the Japanese Society of Gastroenterology. Sendai, Japan, March 24-26, 1988.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1988-12

2.  Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19.

Authors:  Yong-Soon Cho; Jae-Gook Shin
Journal:  Transl Clin Pharmacol       Date:  2022-03-09

3.  Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis.

Authors:  Hyeon Seok Oh; Taehyung Kim; Dong-Hyeon Gu; Tae Suk Lee; Tae Hwan Kim; Soyoung Shin; Beom Soo Shin
Journal:  Molecules       Date:  2022-03-14       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.